Live Cell Imaging Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

Live Cell Imaging Market to surpass USD 3.67 billion by 2030 from USD 1.7 billion in 2018 at a CAGR of 8.52% throughout the forecast period

Clear

Description

Live Cell Imaging Market: Market Segments: By Product (Equipment, Consumable and Software); By Technology (Time-lapse Microscopy, Fluorescence recovery after photobleaching (FRAP), Fluorescence resonance energy transfer (FRET), High content screening (HCS) and Others); By Application (Cell Biology, Developmental Biology, Stem Cell & Drug Discovery and Others); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

Live Cell Imaging Market Overiew

Product Overview
In an in-vivo environment, Live-Cell Imaging is a study that includes real-time observation and measurement of Live-Cells. These Live-Cells are observed under screening systems or microscopes. It offers an in-depth study of cells’ biological functions and pathways. Live-cell imaging has allowed researchers and observers at the molecular level to image cellular activities.

Market Highlights
Live Cell Imaging Market is expected to project a notable CAGR of 8.52% in 2030.
Live Cell Imaging Market to surpass USD 3.67 billion by 2030 from USD 1.7 billion in 2018 at a CAGR of 8.52% throughout the forecast period, i.e., 2019-30. Due to its advantage of providing a detailed study of the cells, live-cell imaging has gained significant attention in the market. Growing research activities around the world have prompted this strategy to be adopted.

The market has been boosted by heavy research work to develop new drugs. The demand for live-cell imaging has also been fueled by increasing incidences of cancer patients and other chronic illnesses.

Live Cell Imaging Market: Segments
Software segment to grow with the highest CAGR of 6.32% during 2019-30
Live Cell Imaging Market is segmented by product as equipment, consumables, and software. The greater market share of XX% in 2018 was accounted by equipment Live Cell Imaging segment of the Live Cell Imaging market which was followed by consumables. Microscopes, cell analyzers, image capturing systems, and standalone systems are part of the equipment segment.

Consumables play a significant role in optimizing the results produced. For time-lapse imaging in which the cells are exposed for a long duration, the optimal dye, probes, and medium are critical. The strength of cells may be adversely influenced by the wrong choice of medium. Many players in the industry are active in the market, such as Thermo Fisher and Enzium Inc.

Live Cell Imaging Market: Market Dynamics
Drivers
Rising Prevalence of Chronic Disease
Global demand for live cell imaging is largely affected by the increasing incidence of chronic diseases and the corresponding need for quick diagnostic techniques. The availability of accurate and precise live cell imaging techniques also helps speed up the processes of drug discovery and other biotechnology research.

In the future, growth in expenditure and funding for the development of advanced cell imaging is also expected to boost the market for live cell imaging.

Restrain
High cost of high-content screening systems
High-content screening (HCS) tools are equipped with advanced functionalities and features and are therefore priced at a premium. As they have limited budgets, academic research laboratories find it hard to afford such high-priced tools. As they require multiple HCS systems in their R&D activities, the high price of these tools is also a concern for several pharmaceutical companies.

Live Cell Imaging Market: Regions
Live Cell Imaging Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.

Live Cell Imaging Market in North America held the largest market share of XX.X% in the year 2018 and will continue its lead through the forecast period. The North American market is largely driven by heavy funding for research and development activities in the region.

On the basis of the rapid adoption of new research technologies, Europe closely follows the North American market. Asia Pacific will be the fastest growing market for live cell imaging because of widespread research and development outsourcing activities.

In addition, Europe held a noteworthy bid due to the early appropriation of innovation. The emerging maturing population calls for focused research on perpetual diseases, such as malignancy, neurodegeneration, and cardiovascular diseases. This has encouraged the investigation and propelled microscopy of immature microorganisms.

Live Cell Imaging Market: Key Players
Becton, Dickinson and Company
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Carl Zeiss AG
• GE Healthcare
• Leica Microsystems
• Olympus Corporation
• Molecular Devices LCC
• Nikon Corporation
• PerkinElmer Inc.
• Sigma-Aldrich Corporation
• Thermo Fisher Scientific Inc
Live Cell Imaging Market report also contains analysis on:
Live Cell Imaging Market Segments:
By Product:
• Equipment
• Consumable
• Software
By Technology:
• Time-lapse Microscopy
• Fluorescence recovery after photobleaching
• Fluorescence resonance energy transfer
• High content screening
• Others
By Application:
• Cell Biology
• Developmental Biology
• Stem Cell & Drug Discovery
• Others
• Live Cell Imaging Market Dynamics
• Live Cell Imaging Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Imaging CRO Market – A Global and Regional Analysis: Focus on Services, Modalities, Applications, Phases, End User, Country Data (11 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2031

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Live Cell Imaging Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Live Cell Imaging Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Live Cell Imaging Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Live Cell Imaging: Market Segmentation
12.1. By Regions
12.1.1. North America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Equipment, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Consumable, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3 By Technology: Market Share (2020-2030F)
12.3.1. Time-lapse Microscopy, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Fluorescence recovery after photobleaching, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Fluorescence resonance energy transfer, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.4. High content screening (HCS), By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.5. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4 By Application: Market Share (2020-2030F)
12.4.1. Cell Biology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.2. Developmental Biology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.3. Stem Cell & Drug Discovery, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.4.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. Company Profile
13.1.1. Becton, Dickinson and Company
13.1.2. Company Overview
13.1.3. Company Total Revenue (Financials)
13.1.4. Market Potential
13.1.5. Global Presence
13.1.6. Key Performance Indicators
13.1.7. SWOT Analysis
13.1.8. Product Launch
13.2. Carl Zeiss AG
13.3. GE Healthcare
13.4. Leica Microsystems
13.5. Olympus Corporation
13.6. Molecular Devices LCC
13.7. Nikon Corporation
13.8. PerkinElmer Inc.
13.9. Sigma-Aldrich Corporation
13.10. Thermo Fisher Scientific Inc

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.